STAT+: Pharmalittle: We’re reading about payments to Russian middlemen, a possible Dupixent rival, and more
Four big drugmakers allegedly paid tens of millions of dollars to middlemen to supply lifesaving drugs to Russian government entities
Four big drugmakers allegedly paid tens of millions of dollars to middlemen to supply lifesaving drugs to Russian government entities